Trial Profile
Efficacy of eltrombopag in newly diagnosed patients with immune thrombocytopenic purpura
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Nov 2015
Price :
$35
*
At a glance
- Drugs Eltrombopag (Primary)
- Indications Idiopathic thrombocytopenic purpura
- Focus Therapeutic Use
- 24 Nov 2015 New trial record